Perrigo | PRGO - Passivo Circulante





Passivo Circulante Alterar Data
AbbVie USD 43.1B 1.46B 2026-09
Abbott USD 16.15B 1.66B 2026-09
Bayer EUR 29.4B 2.87B 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Coherus Biosciences USD 75.51M 56.82M 2026-06
Corcept Therapeutics USD 177.68M 23.87M 2026-09
Dr.Reddys Laboratories INR 154.3B 3.04B 2026-09
Eli Lilly USD 47B 745M 2026-09
J&J USD 55.46B 562M 2026-09
Merck USD 28.8B 1.07B 2026-09
Nestle CHF 45.29B 4.6B 2026-06
Pacira USD 126.1M 4.08M 2026-09
Perrigo USD 1.02B 34.4M 2026-09
Pfizer USD 31.73B 920M 2026-09
Phibro Animal Health USD 295.79M 20.68M 2026-09
Prestige Brands USD 168.5M 14.7M 2026-09
Reckitt Benckiser GBP 7.94B 901M 2024-12
Sanofi EUR 29.77B 2.16B 2026-09
Supernus Pharmaceuticals USD 285.4M 61.98M 2026-09
Teva Pharmaceutical Industries USD 15.42B 221M 2026-09
Xeris Pharmaceuticals USD 134.48M 55.09M 2026-09
Zoetis USD 2.68B 621M 2026-09